Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,099 public trials 2,041 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer

NCT01607892

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +35 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
View Trial Details
Completed

Registry of Patients With Hematologic Disease and COVID-19 in Russia

NCT04422470

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infection and Hematologic Diseases, +20 more
Locations
  • Republican Clinical Hospital of Tatarstan Kazan', Russia
  • City Hospital n.a. V.V. Veresaev Moscow, Russia
  • Clinical Hospital n.a. S.P. Botkin Moscow, Russia
  • N.V. Sklifosovsky Emergency Institute Moscow, Russia
View all 15 locations
View Trial Details
Completed

Study of bb2121 in Multiple Myeloma

NCT02658929

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Stanford Cancer Center Stanford, California, United States
  • National Cancer Institute Bethesda, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details

Related conditions